DJIA 15,843.24 -361.73 -2.23%
NASDAQ 4,230.75 -132.40 -3.03%
S&P 500 1,833.72 -46.33 -2.46%
market minute promo

Celgene (NASDAQ: CELG)

98.52 0.63 (0.64%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $98.44 0.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $96.44
Previous Close $97.89
Daily Range $95.51 - $99.63
52-Week Range $92.98 - $140.72
Market Cap $77.4B
P/E Ratio 20.78
Dividend (Yield) $0.00 (0.0%)
Volume 5,256,007
Average Daily Volume 7,433,528
Current FY EPS $4.19




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

The Silly Reason Why Agios Pharmaceuticals Inc. Was Clobbered in January

Agios Pharmaceuticals actually delivered an encouraging strategic outline at the J.P. Morgan Healthcare Conference, but wound up being derailed by investor sentiment.

3 Health Care Stocks On The Rise

Why Celgene (CELG) Stock Could Increase Today

Barron's: Here Comes $20 Oil

Barron's Picks And Pans: Kinder Morgan, Gilead Sciences And More

ImmunoGen/Merck Collaborate for Ovarian Cancer Study

Leerink Is Back On Board The Biotech Train

See Which Of The Latest 13F Filers Holds Celgene

Why Did Biotech Fall Off a Cliff in January?

Biotech's decline doesn't signal the start of a bear market for the industry. Here's why.

Synthetic Biologics Tanks on Unfavorable Trimesta Data

See More CELG News...

CELG's Top Competitors

CELG $98.52 (0.64%)
Current stock: CELG
AMGN $140.85 (-2.89%)
Current stock: AMGN
GILD $85.53 (0.46%)
Current stock: GILD
$0.00 (0.00%)
Current stock: